Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.

Current influenza vaccines stimulate neutralising antibody to the haemagglutinin antigen but as there is antigenic drift in HA it is difficult to prepare a vaccine in advance against an emergent strain. A potential strategy is to induce CD8(+) and CD4(+) T cells that recognize epitopes within intern...

Full description

Saved in:
Bibliographic Details
Main Authors: Timothy J Powell, Yanchun Peng, Tamara K Berthoud, Marie-Eve Blais, Patrick J Lillie, Adrian V S Hill, Sarah L Rowland-Jones, Andrew J McMichael, Sarah C Gilbert, Tao Dong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0062778&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850224781628014592
author Timothy J Powell
Yanchun Peng
Tamara K Berthoud
Marie-Eve Blais
Patrick J Lillie
Adrian V S Hill
Sarah L Rowland-Jones
Andrew J McMichael
Sarah C Gilbert
Tao Dong
author_facet Timothy J Powell
Yanchun Peng
Tamara K Berthoud
Marie-Eve Blais
Patrick J Lillie
Adrian V S Hill
Sarah L Rowland-Jones
Andrew J McMichael
Sarah C Gilbert
Tao Dong
author_sort Timothy J Powell
collection DOAJ
description Current influenza vaccines stimulate neutralising antibody to the haemagglutinin antigen but as there is antigenic drift in HA it is difficult to prepare a vaccine in advance against an emergent strain. A potential strategy is to induce CD8(+) and CD4(+) T cells that recognize epitopes within internal proteins that are less subject to antigenic drift. Augmenting humoral responses to HA with T cell responses to more conserved antigens may result in a more broadly protective vaccine. In this study, we evaluate the quality of influenza specific T cell responses in a clinical trial using MVA-NP+M1 vaccination followed by influenza virus challenge. In vaccinated volunteers, the expression of Granzyme A, Perforin and CD57 on influenza HLA A*02 M158-66 antigen specific cells was higher than non-vaccinated volunteers before and after challenge despite a similar frequency of antigen specific cells. BCL2 expression was lower in vaccinated volunteers. These data indicate that antigen specific T cells are a useful additional measure for use in human vaccination or immunization studies.
format Article
id doaj-art-58566ee2e0604f2381ddfca4bc296dde
institution OA Journals
issn 1932-6203
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-58566ee2e0604f2381ddfca4bc296dde2025-08-20T02:05:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6277810.1371/journal.pone.0062778Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.Timothy J PowellYanchun PengTamara K BerthoudMarie-Eve BlaisPatrick J LillieAdrian V S HillSarah L Rowland-JonesAndrew J McMichaelSarah C GilbertTao DongCurrent influenza vaccines stimulate neutralising antibody to the haemagglutinin antigen but as there is antigenic drift in HA it is difficult to prepare a vaccine in advance against an emergent strain. A potential strategy is to induce CD8(+) and CD4(+) T cells that recognize epitopes within internal proteins that are less subject to antigenic drift. Augmenting humoral responses to HA with T cell responses to more conserved antigens may result in a more broadly protective vaccine. In this study, we evaluate the quality of influenza specific T cell responses in a clinical trial using MVA-NP+M1 vaccination followed by influenza virus challenge. In vaccinated volunteers, the expression of Granzyme A, Perforin and CD57 on influenza HLA A*02 M158-66 antigen specific cells was higher than non-vaccinated volunteers before and after challenge despite a similar frequency of antigen specific cells. BCL2 expression was lower in vaccinated volunteers. These data indicate that antigen specific T cells are a useful additional measure for use in human vaccination or immunization studies.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0062778&type=printable
spellingShingle Timothy J Powell
Yanchun Peng
Tamara K Berthoud
Marie-Eve Blais
Patrick J Lillie
Adrian V S Hill
Sarah L Rowland-Jones
Andrew J McMichael
Sarah C Gilbert
Tao Dong
Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
PLoS ONE
title Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
title_full Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
title_fullStr Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
title_full_unstemmed Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
title_short Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
title_sort examination of influenza specific t cell responses after influenza virus challenge in individuals vaccinated with mva np m1 vaccine
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0062778&type=printable
work_keys_str_mv AT timothyjpowell examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT yanchunpeng examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT tamarakberthoud examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT marieeveblais examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT patrickjlillie examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT adrianvshill examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT sarahlrowlandjones examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT andrewjmcmichael examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT sarahcgilbert examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine
AT taodong examinationofinfluenzaspecifictcellresponsesafterinfluenzaviruschallengeinindividualsvaccinatedwithmvanpm1vaccine